Wayne Ray

(iStock image)
April 17, 2024

Common AFib drug linked to higher bleeding risk 

In a national retrospective study led by researchers at Vanderbilt University School of Medicine, diltiazem, when given in combination with the anticoagulant drugs apixaban (Eliquis) or rivaroxaban (Xarelto), significantly increased the risk of serious bleeding compared to metoprolol.

By Bill Snyder
December 21, 2021

Study finds apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications

By Jill Clendening
December 12, 2018

High-dose antipsychotics place children at increased risk of unexpected death

Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry.
Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.

By Craig Boerner
x-ray of stomach
December 4, 2018

Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk

A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.

By Jill Clendening
November 10, 2016

VUSM’s MPH Program celebrates 20th anniversary

The Vanderbilt University School of Medicine Master of Public Health (MPH) Program marked its 20th anniversary during Reunion Weekend in October.

By Kathy Whitney
October 13, 2016

Antidepressants’ heart impact less than expected: study

A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks.

By Paul Govern
June 14, 2016

Study shows opioids increase risk of death when compared to other pain treatments

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
By Craig Boerner
January 20, 2015

Vanderbilt study finds use of methadone to treat pain carries increased risk of death

Outside the hospital, use of methadone to treat pain carries a 46 percent increased risk of death when compared to the equally effective but more costly alternative, morphine SR (sustained release).
By Paul Govern
August 22, 2013

Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.
By VUMC News and Communications